Table 1 Comparison of motor map areas across treatment groups.
Vehicle | α2-AR antag. | 2-way ANOVA | |||||
|---|---|---|---|---|---|---|---|
Sham | VNS | Sham | VNS | pDrug [FDrug] | pVNS [FVNS] | pinteraction [Finteraction] | |
Group mean (SEM) | |||||||
Total map area (mm2) | 11.68 (0.63) | 11.29 (1.55) | 13.33 (1.15) | 16.83 (0.93) | 0.003 [10.98] | 0.166 [2.05] | 0.088 [3.20] |
PFL area (mm2) | 2.04 (0.41) | 3.88 (0.57) | 3.00 (0.66) | 2.88 (0.29) | 0.972 [0.00] | 0.099 [2.98] | 0.061 [3.91] |
DFL area (mm2) | 4.57 (0.51) | 3.29 (0.38) | 5.04 (0.51) | 5.96 (0.27) | 0.002 [12.73] | 0.684 [0.17] | 0.021 [6.24] |
Anterior body area (mm2) | 3.61 (0.50) | 3.17 (1.11) | 3.62 (0.49) | 4.63 (0.49) | 0.294 [1.16] | 0.687 [0.17] | 0.305 [1.14] |
Posterior body area (mm2) | 1.46 (0.31) | 0.96 (0.39) | 1.67 (0.50) | 3.38 (0.54) | 0.007 [9.04] | 0.182 [1.91] | 0.019 [6.46] |
PFL representation (% total map) | 17.28 (2.94) | 35.59 (4.16) | 21.50 (3.32) | 17.03 (1.34) | 0.032 [5.3] | 0.037 [4.93] | 0.001 [13.38] |
DFL representation (% total map) | 39.67 (4.21) | 30.23 (2.70) | 38.21 (2.77) | 35.81 (2.15) | 0.526 [0.42] | 0.078 [3.43] | 0.283 [1.22] |
Anterior representation (% total map) | 30.52 (3.28) | 26.62 (5.53) | 28.85 (4.77) | 27.64 (2.77) | 0.938 [0.01] | 0.547 [0.37] | 0.750 [0.10] |
Posterior representation (% total map) | 12.52 (2.57) | 7.56 (3.22) | 11.44 (2.88) | 19.52 (2.28) | 0.062 [3.90] | 0.577 [0.32] | 0.028 [5.6] |